Literature DB >> 19620335

Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.

Kerry L LaPlante1, George Sakoulas.   

Abstract

In an in vitro pharmacodynamic model, linezolid attenuated the activity of aztreonam and ceftazidime against Escherichia coli. Conversely, synergy was detected at 24 and 48 h when daptomycin or vancomycin was added to aztreonam and ceftazidime. We conclude that significant yet underappreciated interactions may occur between gram-positive-spectrum and gram-negative-spectrum antibacterials.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19620335      PMCID： PMC2764192          DOI： 10.1128/AAC.00180-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation.

Authors:  Anja Schumacher; Rainer Trittler; Jürgen A Bohnert; Klaus Kümmerer; Jean-Marie Pagès; Winfried V Kern
Journal:  J Antimicrob Chemother       Date:  2006-09-13       Impact factor: 5.790

2.  Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones.

Authors:  E E McKee; M Ferguson; A T Bentley; T A Marks
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

3.  Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors:  M H LEPPER; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-10

4.  Studies on antibiotic synergism and antagonism; the interference of chloramphenicol with the action of penicillin.

Authors:  E JAWETZ; J B GUNNISON; R S SPECK; V R COLEMAN
Journal:  AMA Arch Intern Med       Date:  1951-03

Review 5.  The search for synergy: a critical review from a response surface perspective.

Authors:  W R Greco; G Bravo; J C Parsons
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

Review 6.  Synergism and antagonism.

Authors:  G M Eliopoulos
Journal:  Infect Dis Clin North Am       Date:  1989-09       Impact factor: 5.982

7.  Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.

Authors:  Kerry L LaPlante; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

8.  The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin.

Authors:  A H Lin; R W Murray; T J Vidmar; K R Marotti
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

9.  Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.

Authors:  K C Lamp; M K Vickers
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

10.  Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.

Authors:  Mark H Wilcox; Kenneth J Tack; Emilio Bouza; Daniel L Herr; Bernhard R Ruf; M Marian Ijzerman; Rodney V Croos-Dabrera; Mark J Kunkel; Charles Knirsch
Journal:  Clin Infect Dis       Date:  2009-01-15       Impact factor: 9.079
View more
  12 in total

1.  Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection Model.

Authors:  Megan K Luther; Louis B Rice; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

2.  A propensity score analysis shows that empirical treatment with linezolid does not increase the thirty-day mortality rate in patients with Gram-negative bacteremia.

Authors:  Hugo-Guillermo Ternavasio-de la Vega; Ana-María Mateos-Díaz; Jose-Antonio Martinez; Manel Almela; Nazaret Cobos-Trigueros; Laura Morata; Cristina De-la-Calle; Marta Sala; Josep Mensa; Miguel Marcos; Alex Soriano
Journal:  Antimicrob Agents Chemother       Date:  2014-09-08       Impact factor: 5.191

3.  Pairwise antibiotic interactions in Escherichia coli: triclosan, rifampicin and aztreonam with nine other classes of antibiotics.

Authors:  Caroline Nguyen; Alice Zhou; Ayesha Khan; Jeffrey H Miller; Pamela Yeh
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

4.  Busting the Myth of "Static vs Cidal": A Systemic Literature Review.

Authors:  Noah Wald-Dickler; Paul Holtom; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2018-04-17       Impact factor: 9.079

5.  Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model.

Authors:  Yiying Cai; Tze-Peng Lim; Jocelyn Qi-Min Teo; Suranthran Sasikala; Eric Chun Yong Chan; Yan Jun Hong; Winnie Lee; Thean Yen Tan; Thuan Tong Tan; Tse Hsien Koh; Li Yang Hsu; Andrea L Kwa
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

6.  Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations.

Authors:  Jordan R Smith; Juwon Yim; Seth Rice; Kyle Stamper; Razie Kebriaei; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

7.  Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia.

Authors:  Andrea Marra; Lucinda Lamb; Ivette Medina; David George; Glenn Gibson; Joel Hardink; Jady Rugg; Jeffrey Van Deusen; John P O'Donnell
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

8.  Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.

Authors:  Megan K Luther; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

9.  Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes.

Authors:  Keiko Tarquinio; Kelsey Confreda; James Shurko; Kerry LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

10.  Rapid Antibiotic Combination Testing for Carbapenem-Resistant Gram-Negative Bacteria within Six Hours Using ATP Bioluminescence.

Authors:  Yiying Cai; Celene L Seah; Hui Leck; Tze-Peng Lim; Jocelyn Q Teo; Winnie Lee; Thuan-Tong Tan; Tse-Hsien Koh; Pui Lai Rachel Ee; Andrea L Kwa
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.